• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Medical Costs Higher for Children With Sickle Cell Disease

Publication
Article
Drug Benefit TrendsDrug Benefit Trends Vol 22 No 4
Volume 22
Issue 4

Children with sickle cell disease (SCD) were shown to have annual medical costs of $9369 (Medicaid) and $13,469 (private insurance), which is significantly higher than that for children without SCD, according to a study led by Djesika D. Amendah, PhD, an economist at the CDC.1 SCD in children resulted in total medical costs of at least $335 million per year in the United States in 2005.

Children with sickle cell disease (SCD) were shown to have annual medical costs of $9369 (Medicaid) and $13,469 (private insurance), which is significantly higher than that for children without SCD,

according to a study led by Djesika D. Amendah, PhD, an economist at the CDC.1 SCD in children resulted in total medical costs of at least $335 million per year in the United States in 2005.

Children with SCD enrolled in Medicaid were shown to have lower medical costs than those with private insurance ($14,722, private insurance; $11,075, Medicaid [Figure]). However, annual average costs of prescription drugs were lower for children with SCD who had private insurance ($531) than they were for those enrolled in Medicaid ($1049).

References:

Reference
1. Amendah DD, Mvundura M, Kavanagh PL, et al. Sickle cell disease-related pediatric medical expenditures in the US. Am J Prev Med. 2010;38(suppl 4):S550-S556.

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
© 2024 MJH Life Sciences

All rights reserved.